Format

Send to

Choose Destination
J Control Release. 2015 Dec 28;220(Pt A):51-60. doi: 10.1016/j.jconrel.2015.09.057. Epub 2015 Oct 5.

Self-assembled 20-nm (64)Cu-micelles enhance accumulation in rat glioblastoma.

Author information

1
Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States.
2
Department of Materials Science & Engineering, University of California, Berkeley, Berkeley, CA, United States.
3
Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States.
4
Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States. Electronic address: kwferrara@ucdavis.edu.

Abstract

There is an urgent need to develop nanocarriers for the treatment of glioblastoma multiforme (GBM). Using co-registered positron emission tomography (PET) and magnetic resonance (MR) images, here we performed systematic studies to investigate how a nanocarrier's size affects the pharmacokinetics and biodistribution in rodents with a GBM xenograft. In particular, highly stable, long-circulating three-helix micelles (3HM), based on a coiled-coil protein tertiary structure, were evaluated as an alternative to larger nanocarriers. While the circulation half-life of the 3HM was similar to 110-nm PEGylated liposomes (t1/2=15.5 and 16.5h, respectively), the 20-nm micelles greatly enhanced accumulation within a U87MG xenograft in nu/nu rats after intravenous injection. After accounting for tumor blood volume, the extravasated nanoparticles were quantified from the PET images, yielding ~0.77%ID/cm(3) for the micelles and 0.45%ID/cm(3) for the liposomes. For GBM lesions with a volume greater than 100mm(3), 3HM accumulation was enhanced both within the detectable tumor and in the surrounding brain parenchyma. Further, the nanoparticle accumulation was shown to extend to the margins of the GBM xenograft. In summary, 3HM provides an attractive nanovehicle for carrying treatment to GBM.

KEYWORDS:

BBB; Blood brain barrier; Drug delivery; Glioblastoma; Liposome; Micelles; Nanoparticle; PET; PET/MR; Positron emission tomography

PMID:
26437259
PMCID:
PMC4688122
DOI:
10.1016/j.jconrel.2015.09.057
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center